Analysis | Metabolite Name | Measured Value | Units | Group |
---|---|---|---|---|
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.4466 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.4553 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.4715 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.4722 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.4738 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.4919 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.4968 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5440 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5459 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5507 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5525 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5548 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5561 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5585 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.5780 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.6218 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.6765 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.6994 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.7204 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.7589 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.7640 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.7674 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.7883 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8021 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8070 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8195 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8198 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8211 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8305 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8380 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8430 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8494 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8506 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8539 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8544 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8677 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8772 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8863 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.8981 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9019 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9064 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9160 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9227 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9291 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9364 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9613 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9637 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9678 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9705 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9721 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9754 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9910 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 0.9974 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0026 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0072 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0193 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0204 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0284 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0312 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0370 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0384 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0463 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0463 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0518 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0594 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0627 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0632 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0674 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0729 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0771 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0797 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0805 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0822 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0827 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0828 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0841 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0916 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0970 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.0988 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1036 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1286 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1335 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1439 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1488 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1541 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1633 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.1961 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.2033 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.2236 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.2258 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.2570 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.2615 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.2704 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.3249 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.3275 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.3380 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.3603 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.3703 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.3736 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.3771 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.4124 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.4622 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.5839 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.8095 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.8361 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-acetylaspartate (NAA) | 1.9640 | Peak area | Diabetic Neuropathy |